Owner IRM LLC Novartis AG.

Inventors Skibinski, David; Valiante, Nicholas; Li, Yongkai; Mishra, Pranab; Wu, Tom Yao-Hsiang; Singh, Manmohan; Zhang, Xiaoyue; Cortez, Alex; Zou, Yefen

Agent Davies Collison Cave

Pub. Number AU-B-2009222105

PCT Pub. Number WO2009/111337

Priority 61/148,336 29.01.09 US; 61/033,139 03.03.08 US

Filing date 27 February 2009

Wipo publication date 11 September 2009

Acceptance publication date 17 May 2012

C07D 221/12 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

A61K 31/4375 (2006.01)

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 471/12 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 491/056 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 491/12 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms